Regulation of Inflammatory Responses in the Cochlea
Regulation of Inflammatory Responses in the Cochlea
批准号:
8580197
负责人:
FEDERICO KALINEC
金额:
$31.68万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-01 至 2015-11-30
关键词:
ATP-Binding Cassette TransportersAddressAnnexin A1AnnexinsAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesApicalApoptosisAuditoryCaviaCell LineCellsClinicalCochleaCochlear ductConfocal MicroscopyCytoplasmElectron MicroscopyFreeze FracturingGlucocorticoidsGoalsGoldImmune responseImmune systemIn VitroInfectionInflammationInflammatoryInflammatory ResponseInjuryIntentionIntracellular TransportKnowledgeLabelLeukocytesLipidsLysophospholipidsMediatingMigration AssayMolecular TargetMyosin ATPaseMyosin Type IINoiseNonmuscle Myosin Type IIAOrganOrgan of CortiOuter Hair CellsPathway interactionsPhasePlayPredispositionPreventionProteinsProteomicsRegulationResolutionRoleSensorineural Hearing LossSiteSmall Interfering RNAStructureSurfaceTechniquesTechnologyTestingTight JunctionsTissuesViruscofilindeafnessextracellularhearing impairmentin vitro Modelin vivo Modelinhibitor/antagonistinsightinterestknock-downlysophosphatidic acidmigrationnon-muscle myosinpreventpublic health relevancerestoration
中文摘要
描述(由申请人提供):炎症是对外来挑战或组织损伤的有益宿主反应,最终导致组织结构和功能的恢复。白细胞向损伤或感染部位的迁移是炎症反应的一个决定性步骤。然而,在哺乳动物耳蜗中,必须阻止白细胞向听觉器官的迁移,因为它可能通过破坏Corti腔边界器官(解剖学上定义为网状层)的紧密连接屏障而消除耳蜗内电位,导致感觉运动外毛细胞凋亡和不可逆的深度耳聋。因此,除非在极端的、不可逆的耳蜗损伤的情况下,在Corti器官中从未发现白细胞。耳蜗阻止白细胞迁移的机制尚不清楚。目前保护Corti器官免受炎症损伤的金标准临床策略是局部递送糖皮质激素。然而,糖皮质激素赋予这种保护作用的机制尚不清楚。这项提议的目标是填补我们知识上的这些空白,这是我们了解哺乳动物耳蜗炎症反应调节的关键一步。我们的初步研究为以下假设提供了强有力的支持:1)膜联蛋白A1 (ANXA1)是先天和适应性免疫系统许多方面的关键调节因子,在阻止白细胞迁移到OC和促进炎症反应的消退阶段发挥重要作用;2)糖皮质激素通过肌球蛋白iic驱动机制刺激豚鼠Hensen细胞释放ANXA1;3) Hensen细胞将ANXA1储存在填充细胞质的突出脂滴内。因此,我们建议使用豚鼠作为体内模型,听觉细胞系作为体外模型,并结合非重叠技术和方法学方法,通过解决以下具体目标来验证这些假设:1)证明Hensen细胞释放的ANXA1能够阻止白细胞迁移;2)阐明ANXA1在细胞内转运和释放的机制;3)鉴定和表征Hensen细胞脂滴储存和释放ANXA1的机制。
英文摘要
DESCRIPTION (provided by applicant): Inflammation is a beneficial host response to foreign challenges or tissue injury that leads ultimately to the restoration of tissue structure and function. Leukocyte migration to sites of injury or infection is a defining step of inflammatory responses. In the mammalian cochlea, however, leukocyte migration into the auditory organ must be prevented as it may abolish the endocochlear potential by disrupting the tight-junction barrier at the organ of Corti luminal border (anatomically defined as the reticular lamina), leading to apoptosis of sensorimotor outer hair cells and irreversible, profound deafness. Thus, leukocytes are never found in the organ of Corti except in cases of extreme, irreversible cochlear damage. The mechanism used by the cochlea to prevent leukocyte migration is still unknown. The current gold standard clinical strategy to protect the organ of Corti against inflammatory damage is the local delivery of glucocorticoids. However, the mechanism by which glucocorticoids confer this protection is also unknown. The goal of this proposal is to fill these gaps in our knowledge, a crucial step in our quest to understand the regulation of inflammatory responses in the mammalian cochlea. Our preliminary studies provide strong support to the following hypotheses: 1) Annexin A1 (ANXA1), a pivotal regulator of many aspects of the innate and adaptive immune systems, have a major role in preventing leukocyte migration into the OC and facilitating the resolution phase of the inflammatory response; 2) glucocorticoids stimulate guinea pig Hensen cells to release ANXA1 via a myosin IIC-driven mechanism; and 3) Hensen cells store ANXA1 inside the prominent lipid droplets filling their cytoplasm. Thus, we propose to use the guinea pig as an in vivo model, an auditory cell line as an in vitro model, and a combination of non-overlapping techniques and methodological approaches to test these hypotheses by addressing the following Specific Aims: 1) Demonstrate that ANXA1 released by Hensen cells prevents leukocyte migration, 2) Elucidate the mechanism/s involved in the intracellular transport and release of ANXA1, and 3) Identify and characterize the mechanism/s involved in the storage and release of ANXA1 by Hensen cell lipid droplets.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.heares.2013.01.020
发表时间:
2013-05
期刊:
Hearing research
影响因子:
2.8
作者:
[Kil SH, Kalinec F]
通讯作者:
Kalinec F
Structural Basis of Outer Hair Cell Function
-
批准号:7878561
-
项目类别:
-
资助金额:$38.27万
-
财政年份:2009
-
负责人:FEDERICO KALINEC
-
依托单位:
Structural Basis of Outer Hair Cell Function
-
批准号:8094316
-
项目类别:
-
资助金额:$37.04万
-
财政年份:2009
-
负责人:FEDERICO KALINEC
-
依托单位:
Regulation of Inflammatory Responses in the Cochlea
-
批准号:8386904
-
项目类别:
-
资助金额:$23.04万
-
财政年份:2009
-
负责人:FEDERICO KALINEC
-
依托单位:
Structural Basis of Outer Hair Cell Function
-
批准号:8288061
-
项目类别:
-
资助金额:$37.04万
-
财政年份:2009
-
负责人:FEDERICO KALINEC
-
依托单位:
Structural Basis of Outer Hair Cell Function
-
批准号:7697862
-
项目类别:
-
资助金额:$38.65万
-
财政年份:2009
-
负责人:FEDERICO KALINEC
-
依托单位:
Regulation of Inflammatory Responses in the Cochlea
-
批准号:8196791
-
项目类别:
-
资助金额:$37.42万
-
财政年份:2009
-
负责人:FEDERICO KALINEC
-
依托单位:
Regulation of Inflammatory Responses in the Cochlea
-
批准号:7993088
-
项目类别:
-
资助金额:$37.42万
-
财政年份:2009
-
负责人:FEDERICO KALINEC
-
依托单位:
Regulation of Inflammatory Responses in the Cochlea
-
批准号:8754804
-
项目类别:
-
资助金额:$12.5万
-
财政年份:2009
-
负责人:FEDERICO KALINEC
-
依托单位:
Structural Basis of Outer Hair Cell Function
-
批准号:8754822
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2009
-
负责人:FEDERICO KALINEC
-
依托单位:
Structural Basis of Outer Hair Cell Function
-
批准号:8495308
-
项目类别:
-
资助金额:$8.74万
-
财政年份:2009
-
负责人:FEDERICO KALINEC
-
依托单位:
Cytoskeletal Regulation of Outer Hair Cell Motility
-
批准号:6603440
-
项目类别:
-
资助金额:$36.45万
-
财政年份:2002
-
负责人:FEDERICO KALINEC
-
依托单位:
Cytoskeletal Regulation of Outer Hair Cell Motility
-
批准号:6758563
-
项目类别:
-
资助金额:$36.45万
-
财政年份:2002
-
负责人:FEDERICO KALINEC
-
依托单位:
Cytoskeletal Regulation of Outer Hair Cell Motility
-
批准号:6545727
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2002
-
负责人:FEDERICO KALINEC
-
依托单位:
Cytoskeletal Regulation of Outer Hair Cell Motility
-
批准号:7435475
-
项目类别:
-
资助金额:$46.25万
-
财政年份:2001
-
负责人:FEDERICO KALINEC
-
依托单位:
海外基金